PATENT CLAIM ANALYSIS

Application Number: 15756342
Application Type: Utility
Filing Date: 2018-02
Publication Date: 2018-10
Patent Classification: ["514", "295000"]

Abstract:
Provided are a conjugate of memantine and arctigenin, and a pharmaceutical composition comprising the conjugate. The conjugate can treat diseases associated with Aβ or Tau protein pathways, such as Alzheimer's disease or Parkinson's disease.

Claim (Index 4):
The conjugate according to  claim 3 , which is a compound of general formula (III), or a pharmaceutically acceptable salt, stereoisomer, polymorph, solvate or prodrug thereof: Linker 3 is a direct bond, or is selected from the group consisting of \u2014C(O)Q 3 N(R 3 )Q 2 -, \u2014C(O)Q 3 N(R 3 )Q 2 N(R 1 )\u2014, \u2014C(O)Q 2 O\u2014, \u2014C(O)Q 2 N(R 1 )\u2014, \u2014C(O)Q 3 N(R 3 )L 1 OQ 2 N(R 1 )\u2014 and \u2014C(O)Q 3 Q 2 N(R 1 )\u2014; L 1 , Q 2 , Q 3 , R 1  and R 3  are as defined in  claim 3 ; and R is selected from the group consisting of H or C1-C6 alkyl.

Metadata:
- Claim Count in Document: 8.0
- Percentile: 88.0
- Lexical Diversity: 1.29032
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['13063525', '16084979', '13940016', '15552556', '13442244']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7845215401811148
- 35 USC 102 Novelty (BERT): 0.49639100207455
- Combined Prediction Score: 0.7557084863704583
- Mean Citation Score: 207.164244
- Max Citation Score: 211.74594
- Similarity Product: 140.2770457551312

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test